Fractional Flow Reserve Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

Fractional Flow Reserve Market is Segmented by Product Type (FFR System and Guidewire), Technology Type (Invasive and Non-Invasive), and Geography (North America, Europe, Asia-Pacific, Middle-East and Africa, and South America).

Fractional Flow Reserve Market Size

Fractional Flow Reserve Market Summary
Study Period 2019 - 2029
Market Size (2024) USD 0.99 Billion
Market Size (2029) USD 1.61 Billion
CAGR (2024 - 2029) 10.08 %
Fastest Growing Market Asia Pacific
Largest Market North America

Major Players

Fractional Flow Reserve Market Major Players

*Disclaimer: Major Players sorted in no particular order

Compare market size and growth of Fractional Flow Reserve Market with other markets in Healthcare Industry

Biotechnology

Pharmaceuticals

Healthcare IT

Medical Devices

Animal Health

Device Drug Combination

Fractional Flow Reserve Market Analysis

The Fractional Flow Reserve Market size is estimated at USD 0.99 billion in 2024, and is expected to reach USD 1.61 billion by 2029, growing at a CAGR of 10.08% during the forecast period (2024-2029).

The healthcare system had witnessed enormous challenges as a result of the COVID-19 pandemic. All outpatient treatments were postponed or restricted during the COVID-19 pandemic to reduce the risk of viral transmission, as most chronic therapies were regarded as non-urgent. It was observed that cardiovascular care delivery during the COVID-19 pandemic period was significantly reduced due to the lag in elective diagnostic testing and face-to-face patient care, as per the article published by the Radiology Cardiothoracic Imaging Society in August 2020. The fractional flow reserve (FFR) measures the ratio of the maximal myocardial blood flow in the presence of a stenosis, helping interventional cardiologists to determine the appropriate use of angioplasty and stenting. Thus, the reduction in cardiovascular services and procedures during the COVID-19 pandemic significantly affected the market's growth. However, cardiovascular patients were recommended to maintain their FFR therapy in order to improve their chances of survival and better control their immune system's capacity to resist the SARS-CoV-2 virus. Such instances bolstered the growth of the market amid the pandemic and are expected to continue the same trend over the next few years, as per the analysis.

The major factors contributing to the market's growth include the higher prevalence of cardiovascular diseases and technological advancements in FFR products.

The wide prevalence of heart diseases in the world is expected to propel the growth of the market over the forecast period. In the year 2020-21, over 14,849 people in the United Kingdom were admitted to hospitals due to heart and circulatory diseases, as per the data published by the British Heart Foundation in February 2022. Likewise, according to the CDC's article titled "Heart Disease Facts" updated in February 2022, heart disease is one of the leading causes of death in the United States. The same source also reports that every year about 659,000 Americans have a heart attack. Thus, the large prevalence of cardiovascular cases around the world creates the need for fractional flow reserves for the diagnosis of coronary artery pressure differences, in turn boosting the market growth. Furthermore, low- and middle-income countries are also witnessing an upsurge in the prevalence of cardiovascular diseases due to a lack of primary healthcare programs that offer early detection and treatment of cardiovascular disorders, according to the data published by the WHO in June 2021. Hence, the market demand for FFR products is likely to increase in these regions over the coming years.

Moreover, the increase in research on the improvisation of fractional flow reserve products is contributing to market growth. For instance, a group of researchers from the United Kingdom and Italy evaluated a clinical solution to improve the fractional flow reserve pullback for the assessment of stenosis in the event of serial disease, as per the data published by the Journal of Invasive Cardiology in July 2021. Such studies regarding the newer inventions related to fractional flow reserves are expected to significantly boost the market's growth over the forecast period.

However, the stringent regulatory framework for fractional flow reserve technologies is expected to slow down the growth of the studied market over the study period.

Fractional Flow Reserve Market Trends

Guidewires Segment is Expected to Hold a Major Market Share in the Fractional Flow Reserve Market

The guidewires segment is expected to grow significantly over the forecast period. Pressure guidewires are used in procedures to determine if any surgery is required in the vessels or arteries of the heart. It also acts as a navigator's tool to reach the lesion. The growing popularity of angiography and its unique characteristics are expected to have a positive influence on this market segment.

The increase in the number of cardiac-related surgeries that require the use of guidewires is expected to boost the growth of the studied segment over the forecast period. For instance, as per the OECD statistics published in November 2022, around 11,029 transluminal coronary angioplasty surgeries were performed in Norway in the year 2021, and nearly 10,330 procedures were performed in Portugal. Thus, the large number of angioplasty procedures is expected to increase the demand for guidewires, which in turn is expected to propel the growth of the market segment over the forecast period.

Moreover, the recent studies focusing on the improvement of existing guidewires are expected to contribute to the growth of the studied segment over the forecast period. For example, a research study by a group of researchers from Egypt examined guidewire insertion in the fractional flow reserve. This study was published by Biomedical Engineering Online in September 2021 and offered a solution to reduce the errors caused by the insertion of fractional flow reserve guidewire. Hence, the rise in research studies focusing on the utilization of guidewires in fractional flow reserves is likely to add to the growth of the guidewires segment over the forecast period.

Several key market players have also played a major role in the growth of the studied segment. For instance, in October 2021, Baylis Medical Company Inc. was acquired by Boston Scientific Corporation for an upfront payment of USD 1.75 billion. The purpose of the acquisition was to increase Boston Scientific's structural heart and electrophysiology product portfolios by bringing in radiofrequency (RF) NRG and VersaCross transseptal platforms. Furthermore, the agreement will help the company acquire a variety of dilators, guidewires, and sheaths for improving healthcare efficiency.

Thus, the guidewires segment is expected to hold a significant market share during the forecast period.

Fractional Flow Reserve Market : Number of Transluminal Coronary Angioplasty Procedures (in Thousands), by Country, 2021

North America is Expected to Hold a Significant Share in the Market and Expected to do Same in the Forecast Period

North America is expected to hold a major market share in the fractional flow reserve market due to the increasing geriatric population linked with cardiovascular diseases and growing technological advancements in FFR monitoring devices.

A large number of people in the region are affected by heart diseases, which is a major factor contributing to the market's growth over the forecast period. For instance, according to the CDC data updated in July 2022, coronary heart disease is the most common type of heart disease, and approximately 20.1 million adults age 20 and older have the disease in the United States. Additionally, as per the same source, every 40 seconds, one individual suffers from a heart attack, and nearly 805,000 people in the United States have a heart attack every year. According to the AHA, by 2035, around 45% of the United States population is likely to suffer from heart disease due to factors like high obesity, high smoking, and unhealthy lifestyles, which may lead to heart attacks and other related issues. The fractional flow reserve method is the most commonly used invasive standard for identifying stenosis in the coronary artery, and the large population affected by heart diseases in the region is likely to add to the growth of the fractional flow reserve market over the forecast period.

Furthermore, as per the study published in IJERPH in January 2022, the geriatric population is more susceptible to developing cardiovascular disease owing to the impairment of the optimal functionality of the cardiovascular system caused by aging. Also, the geriatric population in the United States has been increasing over the years. The number of people over the age of 65 in the United States is projected to reach 80.8 million by the year 2040, and the numbers are projected to rise to 94.7 million by the year 2060, according to the Administration for Community Living, May 2021. The number of people over the age of 85 is projected to be 14.4 million by the year 2040, increasing the demand for FFR products.

Additionally, in July 2021, one of the key players in the FFR market, HeartFlow, announced a merger with Longview Acquisition Corp. II in order to become a publicly traded company. When the proposed deal is completed, the merged company will conduct business as HeartFlow Group Inc. Thus, these aforementioned factors are altogether contributing to the growth of the market in the North American region.

Fractional Flow Reserve Market - Growth Rate by Region

Fractional Flow Reserve Industry Overview

The fractional flow reserve market is fragmented and consists of several major players. In terms of market share, a few of the major players are currently dominating the market. Strategic initiatives taken by companies to develop the product are expected to boost market growth. Some of the companies that are currently dominating the market are Opsens Medical, Abbott, Boston Scientific, GE Healthcare, Siemens Healthcare, Cathworks, Medis Medical Imaging System, Pie Medical Imaging BV, Heartflow Inc., and Koninklijke Philips NV.

Fractional Flow Reserve Market Leaders

  1. Abbott

  2. Boston Scientific

  3. Koninklijke Philips N.V.

  4. Medis Medical Imaging System

  5. GE Healthcare

*Disclaimer: Major Players sorted in no particular order

Fractional Flow Reserve Market Concentration
Need More Details on Market Players and Competitors?
Download PDF

Fractional Flow Reserve Market News

  • July 2022: Medtronic entered into a strategic partnership agreement with CathWorks, a privately held company headquartered in Kefar Sava, Israel, which developed the FFRangio System. As part of the agreement, Medtronic invested up to USD 75 million and immediately began co-promotion of CathWorks' FFRangio System in the United States, Europe, and Japan.
  • February 2022 : Siemens Healthineers expanded its cardiology portfolio with the launch of Artis Icono Biplane, an angiography system with detectors optimized in size for integrated use in the cath lab. The device employs an angio-derived fractional flow reserve (vFFR).

Fractional Flow Reserve Market Report - Table of Contents

1. INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Growing Burden of Cardiovascular Diseases
    • 4.2.2 Advancements in Products
  • 4.3 Market Restraints
    • 4.3.1 Stringent Regulatory Framework
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5. MARKET SEGMENTATION (Market Size by Value - in USD Millions)

  • 5.1 By Product Type
    • 5.1.1 FFR System
    • 5.1.2 Guidewire
  • 5.2 By Technology
    • 5.2.1 Invasive
    • 5.2.2 Non-invasive
  • 5.3 Geography
    • 5.3.1 North America
    • 5.3.1.1 United States
    • 5.3.1.2 Canada
    • 5.3.1.3 Mexico
    • 5.3.2 Europe
    • 5.3.2.1 Germany
    • 5.3.2.2 United Kingdom
    • 5.3.2.3 France
    • 5.3.2.4 Italy
    • 5.3.2.5 Spain
    • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia-Pacific
    • 5.3.3.1 China
    • 5.3.3.2 Japan
    • 5.3.3.3 India
    • 5.3.3.4 Australia
    • 5.3.3.5 South Korea
    • 5.3.3.6 Rest of Asia-Pacific
    • 5.3.4 Middle-East and Africa
    • 5.3.4.1 GCC
    • 5.3.4.2 South Africa
    • 5.3.4.3 Rest of Middle-East and Africa
    • 5.3.5 South America
    • 5.3.5.1 Brazil
    • 5.3.5.2 Argentina
    • 5.3.5.3 Rest of South America

6. COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Abbott
    • 6.1.2 Boston Scientific Corporation
    • 6.1.3 Cathworks
    • 6.1.4 General Electric Company (GE Healthcare)
    • 6.1.5 Heartflow, Inc.
    • 6.1.6 Koninklijke Philips N.V.
    • 6.1.7 Medis Medical Imaging Systems B.V.
    • 6.1.8 OpSens Medical
    • 6.1.9 Pie Medical Imaging B.V.
    • 6.1.10 Siemens Healthcare GmbH
  • *List Not Exhaustive

7. MARKET OPPORTUNITIES AND FUTURE TRENDS

** Subject To Availablity
**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies, and Recent Developments
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

Fractional Flow Reserve Industry Segmentation

As per the scope of this report, fractional flow reserve is a type of procedure that is used for monitoring blood pressure flow through a specific artery. The Fractional Flow Reserve Market is segmented by Product Type (FFR System and Guidewire), Technology Type (Invasive and Non-invasive), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The Market report also covers the estimated market sizes and trends of 17 countries across major regions globally. The report offers the value (in USD million) for the above segments.

By Product Type FFR System
Guidewire
By Technology Invasive
Non-invasive
Geography North America United States
Canada
Mexico
Geography Europe Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Geography Asia-Pacific China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Geography Middle-East and Africa GCC
South Africa
Rest of Middle-East and Africa
Geography South America Brazil
Argentina
Rest of South America
Need A Different Region Or Segment?
Customize Now

Fractional Flow Reserve Market Research FAQs

The Fractional Flow Reserve Market size is expected to reach USD 0.99 billion in 2024 and grow at a CAGR of 10.08% to reach USD 1.61 billion by 2029.

In 2024, the Fractional Flow Reserve Market size is expected to reach USD 0.99 billion.

Abbott, Boston Scientific, Koninklijke Philips N.V., Medis Medical Imaging System and GE Healthcare are the major companies operating in the Fractional Flow Reserve Market.

Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029).

In 2024, the North America accounts for the largest market share in Fractional Flow Reserve Market.

In 2023, the Fractional Flow Reserve Market size was estimated at USD 0.89 billion. The report covers the Fractional Flow Reserve Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Fractional Flow Reserve Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.

Fractional Flow Reserve Industry Report

Statistics for the 2024 Fractional Flow Reserve market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Fractional Flow Reserve analysis includes a market forecast outlook 2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!

Fractional Flow Reserve Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)